Patients with newly diagnosed multiple myeloma and chromosome 1 amplification have poor outcomes despite the use of novel triplet regimens
Year: 2014
Type: article
Study design: Observational Study
Source: American Journal of Hematology
DOI: 10.1002/ajh.23705
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1514044817
